DCC0935 |
Benanserin Hydrochloride |
Inhibitor of monoamine oxidase; Anti-serotonin agent |
|
DCC0936 |
Benazepril |
Inhibitor of angiotensin-converting enzyme (ACE); Prodrug of benazeprilat |
|
DCC0937 |
Benc-511 |
Novel potent PI3K inhibitor, suppressing metastasis of non-small cell lung cancer cells by modulating β-catenin/ZEB1 regulatory loop, blocking AKT phosphorylation |
|
DCC0938 |
Benfluron Hydrochloride |
Novel inhibitor of HIV-1 Rev function, also acting as a cytostatic agent with substantial antiretroviral activity |
|
DCC0939 |
Benmoxin |
Irreversible and nonselective Monoamine_oxidase_inhibitor>monoamine oxidase inhibitor (MAOI) |
|
DCC0940 |
Benorterone |
Antiandrogen, being effective in the treatment of acne, seborrhea, and hirsutism in women |
|
DCC0941 |
Benperidol Hydrochloride |
Potent D2/D4 dopamine receptor antagonist, neuroleptic and antipsychotic |
|
DCC0942 |
Benzavir-1 |
anti-HSV agent |
|
DCC0943 |
Benzobicyclon |
Inhibitor of 4-hydroxyphenylpyruvate dioxygenase (HPPD), acting as a herbicide |
|
DCC0944 |
Benzphetamine Hydrochloride |
Anorectic, primarily promoting weight loss through reduced appetite |
|
DCC0945 |
Benzyl Vinyl Carbonate |
Useful pharmaceutical building block |
|
DCC0946 |
Bepridil |
Long-acting calcium-blocking agent with significant anti-anginal activity |
|
DCC0947 |
Berberine-benzothiazole-2-thiol |
Novel antibacterial agent against multidrug-resistant Escherichia coli at low concentrations as 0.007 mM, disintegrating membrane, accelerating ROS accumulation, reducing bacterial metabolism, and intercalating into DNA groove |
|
DCC0948 |
Berberine-ornidazole |
Novel antibacterial agent against multidrug-resistant Escherichia coli at low concentrations as 0.007 mM, disintegrating membrane, accelerating ROS accumulation, reducing bacterial metabolism, and intercalating into DNA groove |
|
DCC0949 |
Berotralstat Analog |
Novel inhibitor of plasma kallikrein |
|
DCC0950 |
Berotralstat Hydrochloride |
Novel selective inhibitor of plasma kallikrein, blocking the enzymatic activity of plasma kallikrein in releasing bradykinin, the major biologic peptide that promotes swelling and pain associated with attacks of HAE |
|
DCC0951 |
Beta-blocker-15 |
Novel negative allosteric modulator of the ß2-adrenergic receptor (ß2AR), inhibiting cAMP production through the ß2AR, but not that mediated by other Gs-coupled receptors, also inhibiting ß-arrestin recruitment to the activated ß2AR |
|
DCC0952 |
Beta-cit-fp |
Potent ligand of the serotonin (5-HT) and dopamine (DA) transporters used in diagonisis of Parkinson's disease as SPECT imaging precursor |
|
DCC0953 |
Beta-erythroidine Hcl |
Phytoestrogen, possessing typical curare-like action |
|
DCC0954 |
Beta-nor-lapachone |
Natural antibiofilm agent and adjuvant on the antifungal therapy related to resistant infections caused by C. glabrata |
|
DCC0955 |
Betaxolol |
Selective beta-1 adrenergic receptor antagonist with antihypertensive and anti-glaucoma activities and devoid of intrinsic sympathomimetic activity |
|
DCC0956 |
Bet-brd7/9 Inhibitor-12 |
Novel Dual BET-BRD7/9 Bromodomain Inhibitor, showing a strong antiproliferative effect on various cancer cell lines that could not be observed for BD family selective inhibitors |
|
DCC0957 |
Bet-in-36 |
Novel BET inhibitor, selectively targeting BRD4-BD1 bromodomain |
|
DCC0958 |
Betulinic Acid Hydroxamate |
Novel HIF Prolyl Hydrolase Inhibitor, preventing colonic inflammation and fibrosis in murine models of inflammatory bowel disease |
|
DCC0959 |
Bf-170 Hydrochloride |
Novel probe for neurofibrillary tangles (tau fibrils) |
|
DCC0960 |
Bff122 |
Novel potent and selective inhibitor of kynurenine aminotransferase II |
|
DC90961 |
Bff-816
Featured
|
Novel, systemically active kynurenine aminotransferase 2 (KAT2) inhibitor, significantly decreased escape latency in the Morris water maze, indicating improved performance in spatial and contextual memorynovel |
|
DCC0962 |
b-gf-15 |
Potent inhibitor of centrosomal clustering in malignant cells |
|
DCC0963 |
b-glucogallin |
Novel Aldose_reductase_inhibitor>aldose reductase (ALR2) inhibitor |
|
DCC0964 |
Bg-p400-tat |
Novel dual inhibitor of norepinephrine transporter (NET) function and thyrointegrin αvβ3 receptor |
|